Your browser doesn't support javascript.
loading
Ethical Review on Placebo Control in Ophthalmic New Drug Clinical Trials / 中国医学伦理学
Chinese Medical Ethics ; (6): 189-190, 2014.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-446398
Responsible library: WPRO
ABSTRACT
In China , some ophthalmic new drug clinical trials used placebo as control .Two principles should be con-sidered in ethical review when placebo was used in these ophthalmic new drug clinical trials .Firstly, using placebo couldn't lead to irreversible or permanent vision loss .Secondly , there should be proper risk management in protocol and risk dis-closure in consent process .There are several important factors , including effects of standard treatment , risks of using pla-cebo, risk management in protocol and risk information in informed consent form , which should be used to assess the ra-tionality of placebo in ethical review .

Full text: Available Database: WPRIM (Western Pacific) Type of study: Controlled clinical trial / Practice guideline Aspects: Ethical aspects Language: Chinese Journal: Chinese Medical Ethics Year: 2014 Document type: Article
Full text: Available Database: WPRIM (Western Pacific) Type of study: Controlled clinical trial / Practice guideline Aspects: Ethical aspects Language: Chinese Journal: Chinese Medical Ethics Year: 2014 Document type: Article
...